TP53 alterations have been reported to occur in 22% of glioblastomas in general, but in up to 75% of giant cell glioblastomas and these cases result in overexpression in p53 on immunohistochemistry [87,88,89]. This evidence concerns the gene TP53 and glioblastoma.